About Polivy 140mg Injection
Polivy 140mg Injection is a medication used in the treatment of certain types of non-Hodgkin lymphoma. It is an anti-cancer drug that belongs to a class of medications known as antibody-drug conjugates (ADCs). ADCs are designed to target specific proteins on the surface of cancer cells and deliver a potent chemotherapy drug directly to those cells, minimizing damage to healthy cells.
Polatuzumab vedotin is used in combination with other medications for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) or primary mediastinal large B-cell lymphoma (PMBCL) in adults who have received at least two prior therapies.
The dosage of Polivy 140mg Injection is typically administered intravenously (IV), and the specific dosage and schedule will be determined by a healthcare provider based on your individual condition and needs. It’s important to follow your healthcare provider’s instructions and recommendations for this treatment.
Uses Of Polivy 140mg Injection
- Relapsed or refractory DLBCL
- Primary mediastinal large B-cell lymphoma (PMBCL)
- Third-line or later treatment
Benefits Of Polivy 140mg Injection
In Relapsed or refractory DLBCL
Polivy 140mg Injection is used in combination with other medications as part of a treatment regimen for adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). DLBCL is a type of aggressive non-Hodgkin lymphoma, and when it recurs or does not respond to initial treatments, it is considered refractory. Polivy 140mg Injection is used in such cases to improve treatment outcomes.
In Primary mediastinal large B-cell lymphoma (PMBCL)
Polivy 140mg Injection is also indicated for the treatment of primary mediastinal large B-cell lymphoma (PMBCL). PMBCL is a subtype of DLBCL that arises in the mediastinum, the area in the middle of the chest. Polivy 140mg Injection, when combined with other medications, can be used to treat PMBCL in adults.
In Third-line or later treatment
Polivy 140mg Injection is typically administered to patients who have received at least two prior lines of therapy for their lymphoma and have not achieved the desired response. It is considered a treatment option when other therapies have been exhausted.
Side Effects Of Polivy 140mg Injection
- Infusion Reactions
- Low Blood Cell Counts
- Nausea and Vomiting
- Peripheral Neuropathy
- Upper Respiratory Tract Infections
- Liver Function Changes
- Medical Supervision
- Patient Selection
- Infusion Reactions
- Blood Cell Counts
- Liver Function
- Pregnancy and Contraception
- Other Medications
- Driving and Operating Machinery